Heteroaryl imidazolone derivatives as jak inhibitors
申请人:Almirall, S.A.
公开号:EP2397482A1
公开(公告)日:2011-12-21
New heteroaryl imidazolone derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).